DOXYCYCLINE MONOHYDRATE- doxycycline capsule

国家: 美国

语言: 英文

来源: NLM (National Library of Medicine)

有效成分:

DOXYCYCLINE (UNII: N12000U13O) (DOXYCYCLINE ANHYDROUS - UNII:334895S862)

可用日期:

Bryant Ranch Prepack

INN（国际名称）:

DOXYCYCLINE

组成:

DOXYCYCLINE ANHYDROUS 100 mg

给药途径:

ORAL

处方类型:

PRESCRIPTION DRUG

疗效迹象:

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline monohydrate capsules and other antibacterial drugs, doxycycline monohydrate capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections:     Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae .     Respiratory tract infections caused by Mycoplasma pneumoniae .     Lymphogranuloma venereum caused by Chlamydia trachomatis .     Psittacosis (ornithosis) caused by Chlamydophila psittaci .     Trachoma caused by Chlamydia trachomatis , alt

產品總結:

Product: 63629-5361 NDC: 63629-5361-1 30 CAPSULE in a BOTTLE NDC: 63629-5361-2 14 CAPSULE in a BOTTLE NDC: 63629-5361-3 20 CAPSULE in a BOTTLE NDC: 63629-5361-4 12 CAPSULE in a BOTTLE NDC: 63629-5361-5 40 CAPSULE in a BOTTLE NDC: 63629-5361-6 10 CAPSULE in a BOTTLE

授权状态:

New Drug Application Authorized Generic

产品特点

DOXYCYCLINE MONOHYDRATE- DOXYCYCLINE CAPSULE
BRYANT RANCH PREPACK
----------
DOXYCYCLINE MONOHYDRATE CAPSULES_ _
REVISED: JULY 2014
RX ONLY
191157-6
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of doxycycline
monohydrate capsules and other antibacterial drugs, doxycycline
monohydrate capsules should be used
only to treat or prevent infections that are proven or strongly
suspected to be caused by bacteria.
DESCRIPTION
Doxycycline is a broad-spectrum antibacterial synthetically derived
from oxytetracycline. Doxycycline
monohydrate capsules 100 mg, 75 mg, and 50 mg capsules contain
doxycycline monohydrate equivalent
to 100 mg, 75 mg, or 50 mg of doxycycline for oral administration. The
chemical designation of the
light-yellow crystalline powder is alpha-6-deoxy-5-oxytetracycline.
Structural formula:
C
H N O • H O
M.W. = 462.45
Doxycycline has a high degree of lipid solubility and a low affinity
for calcium binding. It is highly
stable in normal human serum. Doxycycline will not degrade into an
epianhydro form.
Inert ingredients: colloidal silicon dioxide; magnesium stearate;
microcrystalline cellulose; sodium
starch glycolate; and a hard gelatin capsule which contains black iron
oxide, red iron oxide, titanium
dioxide, and yellow iron oxide for the 100 mg and 75 mg strengths,
titanium dioxide and yellow iron
oxide for the 50 mg strength. The capsules are printed with edible ink
containing black iron oxide, red
iron oxide, and yellow iron oxide for the 50 mg and 100 mg strengths
and black iron oxide, FD&C Blue
No. 2, FD&C Red No. 40, FD&C Blue No. 1, and D&C Yellow No. 10 for the
75 mg strength.
CLINICAL PHARMACOLOGY
Tetracyclines are readily absorbed and are bound to plasma proteins in
varying degrees. They are
concentrated by the liver in the bile and excreted in the urine and
feces at high concentrations in a
biologically active form. Doxycycline is virtually completely absorbed
after oral administration.
Following a 200 mg dose of doxycycline monohydrate, 24 normal adult
v